Radiomics-based hybrid model for predicting radiation pneumonitis: A systematic review and meta-analysis

被引:3
作者
Sheen, Heesoon [1 ]
Cho, Wonyoung [2 ]
Kim, Changhwan [3 ]
Han, Min Cheol [3 ]
Kim, Hojin [3 ]
Lee, Ho [3 ]
Kim, Dong Wook [3 ]
Kim, Jin Sung [2 ,3 ]
Hong, Chae-Seon [3 ]
机构
[1] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul, South Korea
[2] Oncosoft Inc, Res Inst, Seoul, South Korea
[3] Yonsei Univ, Coll Med, Heavy Ion Therapy Res Inst, Dept Radiat Oncol,Yonsei Canc Ctr, Seoul, South Korea
来源
PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS | 2024年 / 123卷
基金
新加坡国家研究基金会;
关键词
Radiation pneumonitis; Radiomics; Dosiomics; Radiotherapy; Prediction model; Meta-analysis; CELL LUNG-CANCER; RADIOTHERAPY;
D O I
10.1016/j.ejmp.2024.103414
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: This study reviewed and meta -analyzed evidence on radiomics-based hybrid models for predicting radiation pneumonitis (RP). These models are crucial for improving thoracic radiotherapy plans and mitigating RP, a common complication of thoracic radiotherapy. We examined and compared the RP prediction models developed in these studies with the radiomics features employed in RP models. Methods: We systematically searched Google Scholar, Embase, PubMed, and MEDLINE for studies published up to April 19, 2024. Sixteen studies met the inclusion criteria. We compared the RP prediction models developed in these studies and the radiomics features employed. Results: Radiomics, as a single -factor evaluation, achieved an area under the receiver operating characteristic curve (AUROC) of 0.73, accuracy of 0.69, sensitivity of 0.64, and specificity of 0.74. Dosiomics achieved an AUROC of 0.70. Clinical and dosimetric factors showed lower performance, with AUROCs of 0.59 and 0.58. Combining clinical and radiomic factors yielded an AUROC of 0.78, while combining dosiomic and radiomics factors produced an AUROC of 0.81. Triple combinations, including clinical, dosimetric, and radiomics factors, achieved an AUROC of 0.81. The study identifies key radiomics features, such as the Gray Level Co -occurrence Matrix (GLCM) and Gray Level Size Zone Matrix (GLSZM), which enhance the predictive accuracy of RP models. Conclusions: Radiomics-based hybrid models are highly effective in predicting RP. These models, combining traditional predictive factors with radiomic features, particularly GLCM and GLSZM, offer a clinically feasible approach for identifying patients at higher RP risk. This approach enhances clinical outcomes and improves patient quality of life. Protocol Registration: The protocol of this study was registered on PROSPERO (CRD42023426565).
引用
收藏
页数:9
相关论文
共 36 条
  • [1] Severity of radiation pneumonitis, from clinical, dosimetric and biological features: a pilot study
    Aso, Samantha
    Navarro-Martin, Arturo
    Castillo, Richard
    Padrones, Susana
    Castillo, Edward
    Montes, Ana
    Martinez, Jose Ignacio
    Cubero, Noelia
    Lopez, Rosa
    Rodriguez, Laura
    Palmero, Ramon
    Manresa, Federico
    Guerrero, Thomas
    Molina, Maria
    [J]. RADIATION ONCOLOGY, 2020, 15 (01)
  • [2] Recognizing Radiation Therapy-related Complications in the Chest
    Benveniste, Marcelo F.
    Gomez, Daniel
    Carter, Brett W.
    Cuellar, Sonia L. Betancourt
    Shroff, Girish S.
    Benveniste, Ana Paula A.
    Odisio, Erika G.
    Marom, Edith M.
    [J]. RADIOGRAPHICS, 2019, 39 (02) : 344 - 366
  • [3] Combination of Radiomics Features and Functional Radiosensitivity Enhances Prediction of Acute Pulmonary Toxicity in a Prospective Validation Cohort of Patients with a Locally Advanced Lung Cancer Treated with VMAT-Radiotherapy
    Bourbonne, Vincent
    Lucia, Francois
    Jaouen, Vincent
    Pradier, Olivier
    Visvikis, Dimitris
    Schick, Ulrike
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (11):
  • [4] Avoiding Toxicity With Lung Radiation Therapy: An IASLC Perspective
    Bucknell, Nicholas W.
    Belderbos, Jose
    Palma, David A.
    Iyengar, Puneeth
    Samson, Pamela
    Chua, Kevin
    Gomez, Daniel
    McDonald, Fiona
    Louie, Alexander, V
    Faivre-Finn, Corinne
    Hanna, Gerard G.
    Siva, Shankar
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (08) : 961 - 973
  • [5] Differentiation between immune checkpoint inhibitor-related and radiation pneumonitis in lung cancer by CT radiomics and machine learning
    Cheng, Jun
    Pan, Yi
    Huang, Wei
    Huang, Kun
    Cui, Yanhai
    Hong, Wenhui
    Wang, Lingling
    Ni, Dong
    Tan, Peixin
    [J]. MEDICAL PHYSICS, 2022, 49 (03) : 1547 - 1558
  • [6] Radiomics in stereotactic body radiotherapy for non-small cell lung cancer: a systematic review and radiomic quality score study
    Cheung, Ben Man Fei
    [J]. RADIATION ONCOLOGY JOURNAL, 2024, 42 (01): : 4 - 16
  • [7] Using deep learning to predict radiation pneumonitis in patients treated with stereotactic body radiotherapy (SBRT) for pulmonary nodules: preliminary results
    Choi, Kyu Hye
    Seol, Yunji
    Kang, Young-nam
    Lee, Young Kyu
    Ahn, Sang Hee
    Song, Jin Ho
    Choi, Byung-Ock
    Kim, Yeon-Sil
    Jang, HongSeok
    [J]. JOURNAL OF THE KOREAN PHYSICAL SOCIETY, 2022, 81 (05) : 460 - 470
  • [8] Combining handcrafted features with latent variables in machine learning for prediction of radiation-induced lung damage
    Cui, Sunan
    Luo, Yi
    Tseng, Huan-Hsin
    Ten Haken, Randall K.
    El Naga, Issam
    [J]. MEDICAL PHYSICS, 2019, 46 (05) : 2497 - 2511
  • [9] A Novel Nomogram Model Based on Cone-Beam CT Radiomics Analysis Technology for Predicting Radiation Pneumonitis in Esophageal Cancer Patients Undergoing Radiotherapy
    Du, Feng
    Tang, Ning
    Cui, Yuzhong
    Wang, Wei
    Zhang, Yingjie
    Li, Zhenxiang
    Li, Jianbin
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [10] Improvement of Prediction Performance for Radiation Pneumonitis by Using 3-Dimensional Dosiomic Features
    Feng, Aihui
    Huang, Ying
    Zeng, Ya
    Shao, Yan
    Wang, Hao
    Chen, Hua
    Gu, Hengle
    Duan, Yanhua
    Shen, Zhenjiong
    Xu, Zhiyong
    [J]. CLINICAL LUNG CANCER, 2024, 25 (04) : e173 - e180.e2